THE corporatisation of medicine is developing momentum, with advertising restrictions likely to simply be the next tradition to be pared away.Whether this is a good thing or a bad thing, is matter of conjecture.

THE corporatisation of medicine is developing momentum, with advertising restrictions likely to simply be the next tradition to be pared away.Whether this is a good thing or a bad thing, is matter of conjecture.